The immune tolerance network: a new paradigm for developing tolerance-inducing therapies.

@article{Rotrosen2002TheIT,
  title={The immune tolerance network: a new paradigm for developing tolerance-inducing therapies.},
  author={Daniel Rotrosen and Jeff rey B. Matthews and Jeffrey A. Bluestone},
  journal={The Journal of allergy and clinical immunology},
  year={2002},
  volume={110 1},
  pages={
          17-23
        }
}
  • Daniel Rotrosen, Jeff rey B. Matthews, Jeffrey A. Bluestone
  • Published in
    The Journal of allergy and…
     2002
  • Medicine
    • Immune tolerance therapies are designed to reprogram immune cells in a highly specific fashion to eliminate pathogenic responses while preserving protective immunity. A concept that has tantalized immunologists for decades, the development of tolerance-inducing therapies, would revolutionize the management of a wide range of chronic and often debilitating diseases by obviating the need for lifelong immunosuppressive regimens. The advances of the past decade have provided a more detailed… CONTINUE READING
    View PDF

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    22 Citations
    5 Highly Influenced Papers
    5 Cite Background
    5 Cite Methods

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 22 CITATIONS

    Knowledge-data integration for temporal reasoning in a clinical trial system

    VIEW 4 EXCERPTS
    CITES METHODS
    HIGHLY INFLUENCED

    An Ontological Approach to Representing and Reasoning with Temporal Constraints in Clinical Trial Protocols

    VIEW 7 EXCERPTS
    HIGHLY INFLUENCED

    Representing and Reasoning with Temporal Constraints in Clinical Trials Using Semantic Technologies

    VIEW 6 EXCERPTS
    CITES METHODS
    HIGHLY INFLUENCED

    An Ontology-based Architecture for Integration of Clinical Trials Management Applications

    VIEW 10 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Knowledge-Level Querying of Temporal Patterns in Clinical Research Systems

    VIEW 4 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    Modifying the infant's diet to prevent food allergy

    Peripheral blood CD8αα+CD11c+MHC−II+CD3- cells attenuate autoimmune glomerulonephritis in rats

    Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man

    VIEW 1 EXCERPT

    Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC)

    Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches: Workshop Summary

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 29 REFERENCES

    Advances in immune-based therapies to improve solid organ graft survival.

    VIEW 4 EXCERPTS

    Incidence and long-term cost of steroid-related side effects after renal transplantation.

    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL

    Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study

    Systemic Administration of Immunostimulatory DNA Sequences Mediates Reversible Inhibition of Th2 Responses in a Mouse Model of Asthma

    Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

    LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.

    Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

    On the preclinical results of islets and anti-CD154

    • NS Kenyon
    • Graft
    • 2000

    Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.

    Survey of patients after discontinuing venom immunotherapy.